Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71

Journal of Virology

Volumn 86, Issue 10, 2012, Pages 5686-5696

  Yamayoshi, Seiya ^a   Iizuka, Setsuko ^b   Yamashita, Teruo ^c   Minagawa, Hiroko ^c   Mizuta, Katsumi ^d   Okamoto, Michiko ^e,j   Nishimura, Hidekazu ^e   Sanjoh, Kanako ^f   Katsushima, Noriko ^g   Itagaki, Tsutomu ^h   Nagai, Yukio ⁱ   Fujii, Ken ^a   Koike, Satoshi ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b SHIMANE PREFECTURAL INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCE   (Japan)

^c AICHI PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^d YAMAGATA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^e SENDAI CITY MEDICAL CENTER   (Japan)

^f Sanjoh Clinic   (Japan)

^g Katsushima Pediatric Clinic   (Japan)

^h Yamanobe Pediatric Clinic   (Japan)

ⁱ Nagai Children's Clinic   (Japan)

^j TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

SCAVENGER RECEPTOR B; SCAVENGER RECEPTOR B2; UNCLASSIFIED DRUG; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS A; COXSACKIE VIRUS A10; COXSACKIE VIRUS A12; COXSACKIE VIRUS A14; COXSACKIE VIRUS A16; COXSACKIE VIRUS A2; COXSACKIE VIRUS A3; COXSACKIE VIRUS A4; COXSACKIE VIRUS A5; COXSACKIE VIRUS A6; COXSACKIE VIRUS A7; COXSACKIE VIRUS A8; DISEASE ASSOCIATION; DISEASE COURSE; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SEQUENCE; HAND FOOT AND MOUTH DISEASE; HERPANGINA; HUMAN; HUMAN CELL; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEROTYPE; SPECIES DIFFERENTIATION; VIRUS ISOLATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; CELL LINE; CHILD, PRESCHOOL; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; FEMALE; HUMANS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECEPTORS, SCAVENGER; RECEPTORS, VIRUS; SEQUENCE ALIGNMENT; VIRAL PROTEINS;

COXSACKIEVIRUS; ENTEROVIRUS; HUMAN ENTEROVIRUS 71;

EID: 84861303020     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00020-12     Document Type: Article

References (56)

1. Ang LW, et al. 2009. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann. Acad. Med. Singapore. 38:106-112.
2. Baker DA, Phillips CA. 1979. Fatal hand-foot-and-mouth disease in an adult caused by coxsackievirus A7. JAMA 242:1065.
3. Barlean L, Avram G, Pavlov E, Cotor F. 1994. Investigation of five cases of vesicular enteroviral stomatitis with exanthema induced by coxsackie A5 virus. Rev. Roum. Virol. 45:3-9.
4. Bergelson JM. 2010. Receptors, p 73-86. In Ehrenfeld E, Domingo E, Roos RP (ed), The picornaviruses. ASM Press, Washington, DC.
5. Blanz J, et al. 2010. Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase. Hum. Mol. Genet. 19:563-572.
6. Blomqvist S, et al. 2010. Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J. Clin. Virol. 48:49-54.
7. Brown BA, Oberste MS, Alexander JP, Jr, Kennett ML, Pallansch MA. 1999. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 73:9969-9975.
8. Chan YF, AbuBaker S. 2004. Recombinant human enterovirus 71 in hand, foot and mouth disease patients. Emerg. Infect. Dis. 10:1468-1470.
9. Chen SP, et al. 2010. Comparison of clinical features between coxsackievirus A2 and enterovirus 71 during the enterovirus outbreak in Taiwan, 2008: a children's hospital experience. J. Microbiol. Immunol. Infect. 43: 99-104.
10. Dalldorf G. 1953. The coxsackie virus group. Ann. N. Y. Acad. Sci. 56: 583-586.
11. Davia JL, et al. 2011. Onychomadesis outbreak in Valencia, Spain associated with hand, foot, and mouth disease caused by enteroviruses. Pediatr. Dermatol. 28:1-5.
12. De W, et al. 2011. A large outbreak of hand, foot, and mouth disease caused by EV71 and CAV16 in Guangdong, China, 2009. Arch. Virol. 156:945-953.
13. Eskelinen EL, Tanaka Y, Saftig P. 2003. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 13:137-145.
14. Flewett TH, Warin RP, Clarke SK. 1963. 'Hand, foot, and mouth disease' associated with Coxsackie A5 virus. J. Clin. Pathol. 16:53-55.
15. Fuchs R, Blaas D. 2010. Uncoating of human rhinoviruses. Rev. Med. Virol. 20:281-297.
16. Gear JH. 1984. Nonpolio causes of polio-like paralytic syndromes. Rev. Infect. Dis. 6(Suppl 2):S379-S384.
17. Grist NR, Bell EJ. 1984. Paralytic poliomyelitis and nonpolio enteroviruses: studies in Scotland. Rev. Infect. Dis. 6(Suppl 2):S385-S386.
18. Helin I, Widell A, Borulf S, Walder M, Ulmsten U. 1987. Outbreak of coxsackievirus A-14 meningitis among newborns in a maternity hospital ward. Acta Paediatr. Scand. 76:234-238.
19. Huang SC, et al. 2008. Appearance of intratypic recombination of enterovirus 71 in Taiwan from 2002 to 2005. Virus Res. 131:250-259.
20. Itagaki A, et al. 1983. A clustering outbreak of hand, foot, and mouth disease caused by coxsackie virus A10. Microbiol. Immunol. 27:929-935.
21. Kuronita T, et al. 2002. A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. J. Cell Sci. 115:4117-4131.
22. Laszik Z, et al. 1996. P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood 88:3010-3021.
23. Lee HY, et al. 2010. Clinical features of echovirus 6 and 9 infections in children. J. Clin. Virol. 49:175-179.
24. Lin JY, et al. 2008. Heterogeneous nuclear ribonuclear protein K interacts with the enterovirus 71 5' untranslated region and participates in virus replication. J. Gen. Virol. 89:2540-2549.
25. Lin JY, Li ML, Shih SR. 2009. Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation. Nucleic Acids Res. 37:47-59.
26. Lin JY, et al. 2009. hnRNP A1 interacts with the 5' untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. J. Virol. 83:6106-6114.
27. Lin TL, et al. 2008. Rapid and highly sensitive coxsackievirus A indirect immunofluorescence assay typing kit for enterovirus serotyping. J. Clin. Microbiol. 46:785-788.
28. Lo SH, et al. 2011. Clinical and epidemiologic features of coxsackievirus A6 infection in children in northern Taiwan between 2004 and 2009. J. Microbiol. Immunol. Infect. 44:252-257.
29. McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26:91-107.
30. Mizuta K, et al. 2005. Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J. Clin. Microbiol. 43:6171-6175.
31. Mizuta K, et al. 2009. Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine 27:3153-3158.
32. Nakayama T, et al. 1989. Outbreak of herpangina associated with coxsackievirus B3 infection. Pediatr. Infect. Dis. J. 8:495-498.
33. Nishimura Y, et al. 2009. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 15:794-797.
34. Oberste MS, Jiang X, Maher K, Nix WA, Jiang B. 2008. The complete genome sequences for three simian enteroviruses isolated from captive primates. Arch. Virol. 153:2117-2122.
35. Oberste MS, et al. 2005. Enteroviruses 76, 89, 90 and 91 represent a novel group within the species human enterovirus A. J. Gen. Virol. 86:445-451.
36. Oberste MS, Maher K, Pallansch MA. 2007. Complete genome sequences for nine simian enteroviruses. J. Gen. Virol. 88:3360-3372.
37. Oberste MS, Penaranda S, Maher K, Pallansch MA. 2004. Complete genome sequences of all members of the species human enterovirus A. J. Gen. Virol. 85:1597-1607.
38. Ooi MH, et al. 2007. Evaluation of different clinical sample types in diagnosis of human enterovirus 71-associated hand-foot-and-mouth disease. J. Clin. Microbiol. 45:1858-1866.
39. Osterback R, et al. 2009. Coxsackievirus A6 and hand, foot, and mouth disease, Finland. Emerg. Infect. Dis. 15:1485-1488.
40. Pallansch M, Roos R. 2007. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, p 839-893. In Knipe DM, et al (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
41. Podin Y, et al. 2006. Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health 6:180.
42. Ranzenhofer ER, Dizon FC, Lipton MM, Steigman AJ. 1958. Clinical paralytic poliomyelitis due to coxsackie virus group A, type 7. New Engl. J. Med. 259:182.
43. Reczek D, et al. 2007. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell 131: 770-783.
44. Reed LJ, Muench H. 1938. A simple method of estimating 50 percent endpoints. Am. J. Hyg. (Lond.) 27:493-499.
45. Schmidt NJ, Lennette EH, Ho HH. 1974. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129:304-309.
46. Semler B, Wimmer E. 2002. Molecular biology of picornaviruses. ASM Press, Washington, DC.
47. Sickles GM, Mutterer M, Feorino P, Plager H. 1955. Recently classified types of coxsackie virus, group A; behavior in tissue culture. Proc. Soc. Exp. Biol. Med. 90:529-531.
48. Tang WF, et al. 2007. Reticulon 3 binds the 2C protein of enterovirus 71 and is required for viral replication. J. Biol. Chem. 282:5888-5898.
49. Weng KF, Li ML, Hung CT, Shih SR. 2009. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog. 5:e1000593.
50. Yamashita T, Ito M, Taniguchi A, Sakae K. 2005. Prevalence of coxsackievirus A5, A6, and A10 in patients with herpangina in Aichi Prefecture, 2005. Jpn. J. Infect. Dis. 58:390-391.
51. Yamayoshi S, Koike S. 2011. Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J. Virol. 85: 4937-4946.
52. Yamayoshi S, et al. 2009. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 15:798-801.
53. Yang F, et al. 2009. Enterovirus 71 outbreak in the People's Republic of China in 2008. J. Clin. Microbiol. 47:2351-2352.
54. Yip CC, et al. 2010. Emergence of enterovirus 71 "double-recombinant" strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71. Arch. Virol. 155:1413-1424.
55. Yoke-Fun C, AbuBakar S. 2006. Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes. BMC Microbiol. 6:74.
56. Zhang Y, et al. 2010. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol. J. 7:94.